Precursor of Angiotensin II. Ang II is involved in the progression of cervical carcinoma via induction of VEGF secretion through angiotensin II type I receptor. This results in increased invasiveness of carcinoma cells. Correlation of angiotensin II type I R expression with progression from precancerous to invasive cervical carcinoma. This evidence concerns the gene VEGFA and cervical carcinoma.